Ovid Therapeutics Inc.(OVID)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OVID Ovid Therapeutics Inc.

已收盘 05-15 16:00:00 EDT

3.32

+0.09

+2.79%

盘后3.32

+0.000.00%

18:57 EDT

最高3.43	最低3.18	成交量15.51万
今开3.26	昨收3.23	日振幅7.61%
总市值2.35亿	流通市值1.25亿	总股本7,081万
成交额51.53万	换手率0.41%	流通股本3,764万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"OVID","market":"US","secType":"STK","nameCN":"Ovid Therapeutics Inc.","latestPrice":3.32,"timestamp":1715803200000,"preClose":3.23,"halted":0,"volume":155063,"hourTrading":{"tag":"盘后","latestPrice":3.32,"preClose":3.32,"latestTime":"18:57 EDT","volume":1991,"amount":6611.22,"timestamp":1715813864268},"delay":0,"floatShares":37639690,"shares":70810661,"eps":-0.741548,"marketStatus":"已收盘","marketStatusCode":5,"change":0.09,"latestTime":"05-15 16:00:00 EDT","open":3.26,"high":3.4258,"low":3.18,"amount":515341.2276719,"amplitude":0.076099,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.741548,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715846400000},"adr":0,"listingDate":1493956800000,"adjPreClose":3.23,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":3.35,"preClose":3.23,"latestTime":"09:13 EDT","volume":1753,"amount":5872.55,"timestamp":1715778836215},"postHourTrading":{"tag":"盘后","latestPrice":3.32,"preClose":3.32,"latestTime":"18:57 EDT","volume":1991,"amount":6611.22,"timestamp":1715813864268},"volumeRatio":1.741174},"requestUrl":"/m/hq/s/OVID","defaultTab":"news","newsList":[{"id":"2432017655","title":"Ovid Therapeutics Inc    预计每股亏损 22 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432017655","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432017655?lang=zh_cn&edition=full","pubTime":"2024-05-01 23:13","pubTimestamp":1714576422,"startTime":"0","endTime":"0","summary":"   * Ovid Therapeutics Inc     5月3日公布的截至2024年3月31日的财报预计将显示季度收入下降()    * 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于纽约的公司的营收预计将从去年同期的6.616万美元下降10.0%至5.957万美元。* LSEG 分析师对 Ovid Therapeutics Inc 的平均预期是每股亏损 22 美分。* 华尔街对 Ovid Therapeutics Inc 的 12 个月目标价中位数为 8.00 美元，高于其上次收盘价 3.05 美元。5月1日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2431739300","title":"美国研究综述-多米诺比萨、HCA 医疗保健、WW Grainger","url":"https://stock-news.laohu8.com/highlight/detail?id=2431739300","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431739300?lang=zh_cn&edition=full","pubTime":"2024-04-30 16:46","pubTimestamp":1714466797,"startTime":"0","endTime":"0","summary":"    路透4月30日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，包括多米诺比萨、HCA 医疗保健和 WW Grainger 。要点  * 多米诺比萨公司  ：BTIG将目标价从515美元上调至580美元 * HCA Healthcare Inc   ：TD Cowen将目标价从371美元下调至360美元 * Molina Healthcare Inc   ：TD Cowen将目标价从453美元下调至412美元 * 屈臣氏  ：摩根大通将目标价从350美元上调至400美元 * WW Grainger Inc   ：Stephens将目标价从1000美元上调至1250美元 以下是路透周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2431816463","title":"Ovid Therapeutics Inc.盘中异动 下午盘快速拉升6.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431816463","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431816463?lang=zh_cn&edition=full","pubTime":"2024-04-30 01:11","pubTimestamp":1714410679,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日01时11分，Ovid Therapeutics Inc.股票出现波动，股价大幅上涨6.45%。Ovid Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.85%。Ovid Therapeutics Inc.公司简介：Ovid Therapeutics Inc 是一家生物制药公司，致力于减少癫痫发作并切实改善罕见癫痫和癫痫相关神经系统疾病患者的生活。该信息摘要如下：Ovid Therapeutics获HC Wainwright & Co.首次覆盖，给予买入评级, 目标价9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043001111987e84cb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043001111987e84cb8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431839335","title":"Ovid Therapeutics(OVID.US)获HC Wainwright & Co.首次覆盖，给予买入评级, 目标价9.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2431839335","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431839335?lang=zh_cn&edition=full","pubTime":"2024-04-29 18:26","pubTimestamp":1714386369,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics(OVID.US)获HC Wainwright & Co.首次覆盖，给予买入评级, 目标价9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291826158b6194a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291826158b6194a8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430231256","title":"Ovid Therapeutics Inc.盘中异动 股价大跌5.08%报2.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430231256","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430231256?lang=zh_cn&edition=full","pubTime":"2024-04-26 04:01","pubTimestamp":1714075275,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日04时01分，Ovid Therapeutics Inc.股票出现异动，股价快速跳水5.08%。截至发稿，该股报2.99美元/股，成交量7.0695万股，换手率0.10%，振幅4.44%。Ovid Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.09%。Ovid Therapeutics Inc.公司简介：Ovid Therapeutics Inc 是一家生物制药公司，致力于减少癫痫发作并切实改善罕见癫痫和癫痫相关神经系统疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042604011679238aa8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042604011679238aa8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421817275","title":"Ovid Therapeutics Inc.盘中异动 早盘快速拉升5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421817275","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421817275?lang=zh_cn&edition=full","pubTime":"2024-03-22 22:13","pubTimestamp":1711116810,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日22时13分，Ovid Therapeutics Inc.股票出现波动，股价急速上涨5.41%。Ovid Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Ovid Therapeutics Inc.公司简介：Ovid Therapeutics Inc 是一家生物制药公司，致力于减少癫痫发作并显着改善罕见癫痫和癫痫相关神经系统疾病患者的生活。消息层面，截至22时13分，《Ovid Therapeutics董事增持1.82万股普通股股份，价值约5.04万美元》资讯为影响Ovid Therapeutics Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322221331791c4fc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322221331791c4fc2&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ovidrx.com","stockEarnings":[{"period":"1week","weight":0.0767},{"period":"1month","weight":0.0094},{"period":"3month","weight":-0.1432},{"period":"6month","weight":-0.0122},{"period":"1year","weight":-0.0745},{"period":"ytd","weight":0.0031}],"compareEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":0.0244},{"period":"3month","weight":0.0496},{"period":"6month","weight":0.1623},{"period":"1year","weight":0.267},{"period":"ytd","weight":0.101}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ovid Therapeutics Inc.根据特拉华州法律于2014年4月1日成立。该公司是一家专注于为患有罕见神经系统疾病的患者和家庭开发有影响力的药物的生物制药公司。该公司认为，这些疾病是药物开发的一个有吸引力的领域，因为在过去几年中对潜在生物学的理解已经有意义的增长;但仍被行业忽视。其经验丰富的团队开始了将罕见神经病学的生物学和症状学整合的愿景，为其候选药物的开发采用创新研究和临床策略。使用遗传学和大脑生物学途径的最新科学进步，该公司已经创建了疾病相关途径的蓝图，以鉴定和获得用于治疗罕见神经系统疾病的新化合物。该公司正在执行其战略，在许可证领域与领先的生物制药公司和学术机构合作。该公司正在开发一个强大的临床资产管道，最初的重点是神经发育障碍和罕见的癫痫性脑病。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.074328},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.063006},{"month":3,"riseRate":0.428571,"avgChangeRate":0.010165},{"month":4,"riseRate":0.571429,"avgChangeRate":0.127318},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.017207},{"month":6,"riseRate":0.428571,"avgChangeRate":0.069439},{"month":7,"riseRate":0.428571,"avgChangeRate":0.005724},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.079959},{"month":9,"riseRate":0.285714,"avgChangeRate":0.085539},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.130522},{"month":11,"riseRate":0.571429,"avgChangeRate":0.253884},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.17063}],"exchange":"NASDAQ","name":"Ovid Therapeutics Inc.","nameEN":"Ovid Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ovid Therapeutics Inc.(OVID)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ovid Therapeutics Inc.(OVID)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ovid Therapeutics Inc.,OVID,Ovid Therapeutics Inc.股票,Ovid Therapeutics Inc.股票老虎,Ovid Therapeutics Inc.股票老虎国际,Ovid Therapeutics Inc.行情,Ovid Therapeutics Inc.股票行情,Ovid Therapeutics Inc.股价,Ovid Therapeutics Inc.股市,Ovid Therapeutics Inc.股票价格,Ovid Therapeutics Inc.股票交易,Ovid Therapeutics Inc.股票购买,Ovid Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ovid Therapeutics Inc.(OVID)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ovid Therapeutics Inc.(OVID)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况